Commonwealth Equity Services’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $92K | Sell |
|
|||||
|
2025
Q2 | $80K | Buy |
|
|||||
|
2025
Q1 | $64K | Buy |
|
|||||
|
2024
Q4 | $97K | Buy |
|
|||||
|
2024
Q3 | $59K | Buy |
|
|||||
|
2024
Q2 | $21K | Sell |
|
|||||
|
2024
Q1 | $40K | Buy |
|
|||||
|
2023
Q4 | $17K | Sell |
|
|||||
|
2023
Q3 | $30K | Buy |
|
|||||
|
2023
Q2 | $60K | Buy |
|
|||||
|
2023
Q1 | $47 | Buy |
|
|||||
|
2022
Q4 | $83K | Buy |
|
|||||
|
2022
Q3 | $116K | Hold |
|
|||||
|
2022
Q2 | $98K | Buy |
|
|||||
|
2022
Q1 | $133K | Sell |
|
|||||
|
2021
Q4 | $238K | Sell |
|
|||||
|
2021
Q3 | $297K | Sell |
|
|||||
|
2021
Q2 | $424K | Sell |
|
|||||
|
2021
Q1 | $457K | Buy |
|
|||||
|
2020
Q4 | $327K | Sell |
|
|||||
|
2020
Q3 | $210K | Sell |
|
|||||
|
2020
Q2 | $209K | Buy |
|
|||||
|
2020
Q1 | $106K | Sell |
|
|||||
|
2019
Q4 | $220K | Buy |
|
|||||
|
2019
Q3 | $137K | Buy |
|
|||||
|
2019
Q2 | $156K | Sell |
|
|||||
|
2019
Q1 | $148K | Sell |
|
|||||
|
2018
Q4 | $314K | Sell |
|
|||||
|
2018
Q3 | $471K | Buy |
|
|||||
|
2018
Q2 | $250K | Buy |
|
|||||
|
2018
Q1 | $288K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $168K | Hold |
|
|||||
|
2017
Q2 | $99K | Buy |
|